Published in:
Open Access
01-12-2007 | Case report
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Authors:
Tricia MM Tan, Carmela Caputo, Amrish Mehta, Emma CI Hatfield, Niamh M Martin, Karim Meeran
Published in:
Journal of Medical Case Reports
|
Issue 1/2007
Login to get access
Abstract
Background
Pituitary apoplexy is a life-threatening endocrine emergency that is caused by haemorrhage or infarction of the pituitary gland, commonly within a pituitary adenoma. Patients classically present with headache, ophthalmoplegia, visual field defects and altered mental state, but may present with a typical symptoms such as fever and altered conscious level.
Case presentation
A 57-year-old female with a known pituitary macroadenoma was treated for suspected acute coronary syndrome with aspirin, clopidogrel and full dose enoxaparin. She developed a severe and sudden headache, nausea and vomiting and visual deterioration. A CT scan showed haemorrhage into the pituitary macroadenoma. She underwent neurosurgical decompression. Post-operatively her visual fields and acuity returned to baseline. She was continued on hydrocortisone and thyroxine replacement on discharge.
Conclusion
This case illustrates the risks of anticoagulation in a patient with a known pituitary macroadenoma, and raises the issue of whether these tumours present a relative contraindication to the use of dual antiplatelet and anticoagulation in acute coronary syndrome.